作者
Marc Evans, Ruth D Lewis, Angharad R Morgan, Martin B Whyte, Wasim Hanif, Stephen C Bain, Sarah Davies, Umesh Dashora, Zaheer Yousef, Dipesh C Patel, W David Strain
发表日期
2022/1
来源
Advances in therapy
卷号
39
期号
1
页码范围
33-43
出版商
Springer Healthcare
简介
Chronic kidney disease (CKD) is a complex disease which affects approximately 13% of the world’s population. Over time, CKD can cause renal dysfunction and progression to end-stage kidney disease and cardiovascular disease. Complications associated with CKD may contribute to the acceleration of disease progression and the risk of cardiovascular-related morbidities. Early CKD is asymptomatic, and symptoms only present at later stages when complications of the disease arise, such as a decline in kidney function and the presence of other comorbidities associated with the disease. In advanced stages of the disease, when kidney function is significantly impaired, patients can only be treated with dialysis or a transplant. With limited treatment options available, an increasing prevalence of both the elderly population and comorbidities associated with the disease, the prevalence of CKD is set to rise. This …
引用总数